Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings ...
Hosted on MSN1mon
Rodman & Renshaw sets Talphera stock Buy rating, $4 targetOn Tuesday, Rodman & Renshaw initiated coverage on shares of biopharmaceutical company Talphera (NASDAQ: TLPH) with a Buy rating and a price target of $4.00. The firm's analysts highlighted ...
For TW, they had the tough task of taking on HomeBois, while TS was facing off against Liquid Echo. In the end ... This series was another quick one, with TLPH absolutely destroying HB, constantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback